, Singapore
110 views

Medtech startup NDR Medical closes $8m in series A funding

The firm aims to prepare for the expansion into the US.

Singapore-based surgical robotic firm NDR Medical Technology has raised $8m in a series A round led by Microport Scientific Corporation (MicroPort), a press release revealed.

Other investors who participated include existing investor SGInnovate, and a new investor Kava Ventures, a venture partnership founded by owners of an established medical technology distributor in Southeast Asia.

NDR will be establishing a joint venture in China with MicroPort Urocare (Jiaxing)(MicroPort Urocare), a subsidiary of MicroPort. This is said to advance NDR’s entry into the China market, tapping on existing networks and engineering resources that the partnership brings.

This investment is MicroPort’s first equity investment into a Singapore-based startup and signifies the company’s growing interest in potential investment and collaboration opportunities within the region.

The startup will use the fresh capital to prepare for the expansion into the US, regulatory submission across other major markets, and to further enhance the team’s technical capabilities and explore other clinical applications for the product.

NDR has developed an Automated Needle Targeting system known as ANT, for robotic-guided access to obtain precise targeting. The system uses artificial intelligence (AI) and medical image processing to identify the targeted lesion and perform insertion trajectory planning, with the robot executing a range of motion to assist surgeons in obtaining accurate access. 

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Top News

Access Partnership closes $16.6m raise with Mayfair and Kartesia
The firm plans to use the capital for acquisitions and to deepen its global footprint.
Saudi Arabia may set up crude oil storage in Singapore
The joint venture will commence in Jurong Island in the second half of 2027.